Clarivate

FEBRUARY 28, 2023

In recent years, we’ve seen an increase in awareness among healthcare providers and better diagnosis of rare diseases, leading to improved access to care for patients with these uncommon conditions. 9; 9/2017; p447; DOI:10.1016/j.je.2017.02.001 Frontiers in Pharmacology; 13:1089033; DOI: 10.3389/fphar.2022.1089033

Patients 98

Patients Prescription Pharmacology Healthcare 98

Pharmaceutical Technology

AUGUST 8, 2022

In 2017, the US Food and Drug Administration (FDA) broke ground by approving the first drug with an embedded biosensor to track its use. It potentially helps individuals lend some kind of concrete evidence to discussions with their healthcare provider. Proteus’s profile grew considerably; it was soon valued at $1.5

Food and Drug Administration 122

Food and Drug Administration FDA Medicine Patients 122

Pharmaceutical Technology

NOVEMBER 3, 2022

According to some estimates, between 2017 and 2047, the number of individuals living with stroke will increase by 27% in the EU. As a result, healthcare providers need to rely on generic manufacturers, but there are only a few who make them, he explains. And patients can die when we do not have these readily available,” he says.

Medicine 111

Medicine Manufacturing Pharmacology Healthcare 111